基于重组策略的一体化生物加工过程最新进展

Advances of consolidated bioprocessing based on recombinant strategy

木质纤维素材料具有储量丰富、原料成本低及可再生等优点,人们期望其能替代石油作为原料来生产多种燃料和化学品,如生物柴油、生物氢、生物乙醇等,而木质纤维素解聚过程的高成本成为实现这一过程的主要障碍。一体化生物加工过程(Consolidated bioprocessing,CBP)是指在不添加任何外源水解酶的情况下,直接将木质纤维素原料一步转化为生物化学品的生物加工过程。通过基因工程,将水解酶的生成、木质纤维素的降解和生物产品的生产等功能集成到一个生物体上。对于CBP,人们通常有两种策略可供选择,即本地策略和重组策略。文中重点介绍了基于重组策略的CBP的原理、两种不同的应对方式、合成生物学及代谢工程对其的贡献以及未来所面临的挑战与展望。

Lignocellulosic biomass represents an abundant, low-cost and renewable source of potentially fermentable sugars. It is acandidate besides petroleum as feedstock for fuel and chemical production. Recent researches on utilizing lignocellulosicsas feedstock boost development of numerous-promising processes for a variety of fuels and chemicals, such as biodiesel, biohydrogen and ethanol. However, high cost in depolymerization is a primary obstacle preventing the use of lignocellulosic biomass as feedstock. Consolidated bioprocessing （CBP）, refers to the bioprocess without any exogenous cellulolyotic enzymes added, converting the lignocellulosic material into biochemicals directly, which could potentially avoid the cost of the dedicated enzyme generation step by incorporating enzyme-generating, biomass-degrading and bioproduct-producing capabilities into a single organism through genetic engineering. There are two CBP strategies, native strategy and recombinant strategy. We mainly introduce the recombinant strategy, including its principle, the two responding styles, the contributions of synthetic biology and metabolic engineering and the future challenges.